Pharma & Biotech
-
Nabriva Therapeutics of King of Prussia gets OK from FDA for pneumonia drug
Nabriva Therapeutics’ drug application for its antibiotic Xenleta recently got the approval from the Food and Drug Administration. The antibiotic treats community-acquired bacterial pneumonia (CABP), a leading cause of infection-related deaths in the United States. Based in King of Prussia, Nabriva claims about 5 million cases of pneumonia are reported in the United States each…
-
Plymouth Meeting marijuana start up Ilera Healthcare fetches $125 million
Plymouth Meeting medical marijuana start-up Ilera Healthcare, announced on that it was being acquired by the massive Canadian cannabis company, TerrAscend, in a deal that was valued at $125 million to $225 million, writes Sam Wood for the Philadelphia Inquirer. The higher $225 million valuation is based on future profit prediction models. [uam_ad id=”54865″] Ilera…
-
Grassroots Cannabis to open new Herbology dispensary in KOP
Grassroots Cannabis will open a new Herbology dispensary on July 22nd, located at 1036 DeKalb Pike in King of Prussia, PA. Grassroots Cannabis grows, processes and sells cannabis through its unique, vertically integrated business model and is one of the largest multi-state cannabis companies in the nation. “We are thrilled to continue to expand our…
-
Merck acquires Tilos Therapeutics for $733 million
Merck & Co. Inc, makes its second massive deal with a cancer therapy developer recently. The company made an agreement to purchase Tilos Therapeutics for up to $773 million, writes John George for bizjournals.com. Merck is headquartered in Kenilworth, NJ and is one of the largest pharmaceutical companies in the world. [uam_ad id=”54865″] Tilos Therapeutics…
-
Biotech co-working project with $500 million price tag coming to King of Prussia
A new bio-tech campus with co-working space will continue to solidify Montgomery County and Southeastern Pennsylvania as one of the nations leading biotech corridors. MLP Ventures, a King of Prussia-based investment firm, intends to use the former GlaxoSmithKline campus at 709 Swede Street, along with an adjacent office park to create a nearly 2 million…
-
SAPA-GP holds annual conference in King of Prussia
Despite recent breakthroughs in the pharmaceutical industry, there are still significant unmet medical needs around the world. On May 31st, 2019, Sino-American Pharmaceutical Professionals Association-Greater Philadelphia (SAPA-GP), a non-profit professional organization in Philadelphia area, brought global researchers, business leaders, and investors together at its 17th Annual Conference in King of Prussia at the Sheraton Valley…
-
Montco DA’s Office and Police Chiefs organize Drug Take Back Day
Forty-three locations throughout Montgomery County will be collecting unwanted, unneeded and expired medications as part of Drug Take Back Day, this Saturday, organized by the Montgomery County District Attorney’s Office and the Police Chiefs Association of Montgomery County. The event runs 10 a.m. to 2 p.m., Saturday, April 27, 2019. While most locations are police…
-
MCCC to hold Red Cross Blood Drive and Wellness Fair
February is American Heart Month, and one of the best health-related activities you can do this month is to give the gift of life through donating blood. You can make your donation at Montgomery County Community College’s American Red Cross Community Blood Drive and Wellness Fair on Wednesday, Feb. 27, at West Campus, South Hall…
-
‘New’ East Norriton Pharmacy celebrates grand opening
Several months after a soft opening, the owners of a new pharmacy in East Norriton decided it was time to tell everyone they’re open and ready to help take care of you. On Saturday, November 17 the East Norriton Pharmacy celebrated the opening of a new independent pharmacy with a Ribbon Cutting Ceremony at their 215 W.…
-
Paratek Pharmaceuticals Inc. gets 2 FDA approvals in less than 24 hours
Things are looking pretty good for Paratek Pharmaceuticals Inc., a Boston-based biopharmaceutical company that has a huge presence in King of Prussia. The federal agency granted marketing clearance to Nuzyra, an antibiotic developed by Paratek (NASDAQ: PRTK) to treat adults with community-acquired bacterial pneumonia and acute skin and skin structure infections. Nuzyra, according to the company,…
-
Harmony Biosciences opens new Plymouth Meeting HQ
Harmony Biosciences officially opened its new corporate headquarters Wednesday at 630 W. Germantown Pike, Plymouth Meeting. The privately owned biopharmaceutical company,, founded in 2017, focuses on developing new treatments for people living with rare diseases, writes John George at bizjournals.com. [uam_ad id=”54865″] Among those attending the company’s grand opening ceremony for its new headquarters was…
-
Denied FDA approval for pain medication, Recro Pharma tries again
Malvern-based Recro Pharma, whose application to market a non-opioid pain medication was denied by the U.S. Food and Drug Administration, plans to resubmit the application by the end of September. The drug, known as melixicam, is taken intravenously for the management of moderate to severe pain, writes John George at bizjournals.com. [uam_ad id=”54865″] In turning…
-
Scientist admits plot to steal plans from GlaxoSmithKline
A biochemist has admitted in court that she stole information from GlaxoSmithKline’s Upper Merion research plant, intending to launch a rival company in China with the backing of the Chinese government. Yu Xue, 48, of Wayne, told a federal judge in Philadelphia that she appropriated research on cancer and other therapies, many of which she…
-
Biocoat, Inc., based in Horsham, partners with Adam Spence on an integrated solution to streamline development of reinforced catheters
A new strategic partnership between Biocoat, Inc. andAdam Spence, a Spectrum Plastics Group Company, will streamline the process of producing catheters used in vital vascular procedures, such as angioplasty, bypass surgery, fluid drainage, and other essential treatments. The partnership allows Adam Spence’s innovative reinforced catheter shafts to receive Biocoat’s industry-leading hydrophilic coatings. Biocoat Inc. has facilities in Horsham.…
-
Antibiotic developed by Paratek, with a location in King of Prussia, gets FDA approval
Paratek Pharmaceuticals’ experimental antibiotic used to treat skin infections and pneumonia received recommended approval by a Food and Drug Administration advisory panel. The FDA’s Antimicrobials Drug Advisory Committee voted 17-to-1 to recommend approval of the new drug candidate, an antibiotic called omadacycline, for the treatment of acute bacterial skin and skin structure infections. The committee…
-
AmerisourceBergen seeks good will in face of opioid epidemic
AmerisourceBergen, a company that ranks No. 12 on the Fortune 500, established its namesake AmerisourceBergen Foundation as a public charity in 2014. But its initiatives on the opioid epidemic have proliferated this year, as manufacturers and distributors have come under assault by virtually every level of government, writes Catherine Dunn at philly.com. [uam_ad id=”54865″] The foundation –…
-
Inovio, Plymouth Meeting, enters partnership for immunotherapy study
Inovio Pharmaceuticals, Inc. has entered into a partnership with the AIDS Malignancy Consortium to evaluate VGX-3100 as a potential therapy for HIV-positive adult men and women. The Plymouth Meeting-biopharmaceutical company is developing VGX-3100, an immunotherapy designed to boost the ability of person’s immune system to fight diseases, as a treatment for human papillomavirus (HPV)-associated precancerous…
-
Tiny Madrigal’s stock is soaring as it advances an experimental drug targeting NASH
Madrigal Pharmaceuticals can’t stay hidden in West Conshohocken much longer. The 7-year-old company has experienced a rapid rise in its stock price and market capitalization, which at the start of the week was at $4.4 billion. That’s billion, with a “b,” for a company with just 10 employees, writes John George in the Philadelphia Business…
Founding Partners
Advertisement
Affiliate Partners
Community Partners
